Compound Detail
CHEMBL304902
CLOTHIAPINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL304902 |
| Name | CLOTHIAPINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | KAAZGXDPUNNEFN-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
9
Activities
1
Assay Types
0
PK Parameters
20
Publications
5
Known Names
1
Indications
3
Mechanisms
Molecular Properties
343.9
MW (Da)
4.13
ALogP
4
HBA
0
HBD
18.8
PSA (Ų)
0.72
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 2 (5-HT2) receptor antagonist | ANTAGONIST | Serotonin 2 (5-HT2) receptor | ✓ | ✓ |
| Dopamine D4 receptor antagonist | ANTAGONIST | D(4) dopamine receptor | ✓ | ✓ |
| Serotonin 3 (5-HT3) receptor antagonist | ANTAGONIST | Serotonin 3 (5-HT3) receptor | ✓ | ✓ |
Indications
Psychotic Disorders
ATC Classification
N05AH06
clotiapine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 9 meas. best 9.31
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL217 | Ki | 9.31 | 9.31 | 0.5 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 9.23 | 9.225 | 0.6 | 2 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.36 | 8.355 | 4.4 | 2 |
| D(1A) dopamine receptor CHEMBL265 | Ki | 7.85 | 7.85 | 14.0 | 2 |
| Muscarinic acetylcholine receptor CHEMBL1907609 | Ki | 6.87 | 6.87 | 134.9 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 20031418 | 10.1016/j.bmc.2009.11.060 | Unchecked | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 7907148 | 10.1021/jm00030a011 | Rattus norvegicus | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(3) dopamine receptor | 2 |
| 8101877 | 10.1021/jm00067a009 | Rattus norvegicus | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 2 |
Data from ChEMBL 36 via Core Engine